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Abstract The use of whole exome sequencing (WES) for
diagnostics of children with rare genetic diseases raises ques-
tions about best practices in genetic counselling.While a lot of
attention is now given to pre-test counselling procedures for
WES, little is known about how parents experience the (pos-
itive, negative, or inconclusive) WES results in daily life. To
fill this knowledge gap, data were gathered through in-depth
interviews with parents of 15 children who underwent WES
analysis. WES test results, like results from other genetic tests,
evoked relief as well as worries, irrespective of the type of
result. Advantages of obtaining a conclusive diagnosis includ-
ed becoming more accepting towards the situation, being en-
abled to attune care to the needs of the child, and better coping
with feelings of guilt. Disadvantages experienced included a
loss of hope for recovery, and a loss by parents of their social
network of peers and the effort necessary to re-establish that
social network. While parents with conclusive diagnoses were
able to re-establish a peer community with the help of social
media, parents receiving a possible diagnosis experienced
hurdles in seeking peer support, as peers still needed to be
identified. These types of psychosocial effects of WES test
results for parents are important to take into account for the
development of successful genetic counselling strategies.
Keywords Whole exome sequencing . Genetic counselling .
Parental experiences . Rare diseases . Psychosocial
Introduction
Parents of children with rare genetic diseases such as intellec-
tual disability, neurodegenerative disorders, and/or epileptic en-
cephalopathies, typically spend years searching for a diagnosis,
causing emotional turmoil (Carmichael et al. 2015; Graungaard
and Skov 2006). This extensive search for a diagnosis is some-
times termed a Bdiagnostic odyssey,^ that is, parents bring their
children to different specialists, where they are subjected to
myriad examinations and tests (Carmichael et al. 2015).
Despite all of these tests, a definitive diagnosis is reached in
less than 50 % of cases. The introduction of Next Generation
Sequencing (NGS) technologies, allowing geneticists to exam-
ine the entire genome or the protein-coding part of the genome,
the exome, in a single test, is considered promising as NGS
increases the chance of finding a disease-causing mutation.
Recent studies have confirmed that Whole Exome
Sequencing (WES) increases the amount of diagnoses for chil-
dren with hitherto unexplained developmental delay (De Ligt
et al. 2012; Iglesias et al. 2014; Vissers et al. 2010). Therefore,
WES is increasingly used as a first-tier diagnostic test in clinical
practice for clinically and genetically heterogeneous disorders.
This diagnostic development raises questions, however,
about genetic counselling strategies. Currently much attention
is given to the information that should be provided in the pre-
test counselling procedure prior to the child’s (and parents’)
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participation in WES trials, such as information on informed
consent and the possibility of incidental findings (Appelbaum
et al. 2014; Krabbenborg et al. 2015; Rigter et al. 2013; Hitch
et al. 2014; Levenseller et al. 2013; Roche and Palmer 2014;
Sapp et al. 2013; Tabor et al. 2012). Little is known, however,
about how parents process and experience a (positive, nega-
tive, or inconclusive) result fromWESwhen they return home
to their daily lives with their child. To provide adequate psy-
chosocial support and sufficient information in pre- and post-
counselling related to WES diagnostics, it is critically impor-
tant for providers to know about these parental experiences.
Such knowledge will allow genetic counsellors and other
medical specialists to anticipate disappointments and ques-
tions that WES results may raise for parents. The purpose of
this study was to investigate these psychosocial aspects.
Specifically, we explored how a diagnosis impacts daily life
by asking parents what they perceive as the benefits and the
disadvantages they experienced after receiving WES results.
Methods
Diagnostic Exome Sequencing Process
This research is part of a multidisciplinary translational study that
took place at the Radboud University Medical Center
(Radboudumc), involving the departments of Human Genetics,
Pediatric Neurology, andHealth Evidence, as well as the Institute
for Quality of Healthcare. Between September 2011 and March
2012, 50 children (<18 yrs) with complex pediatric neurological
problems of presumed genetic origin were included. They pre-
sented with clinically and genetically heterogeneous disorders,
such as intellectual disability, movement disorders, epileptic sei-
zures, muscle disorders, and/or speech disorders. Diagnostic se-
quencing was performed as described in a previous study (De
Ligt et al. 2012), and diagnostic outcomeswere communicated to
parents over the course of 2013 and 2014. Three types of diag-
nostic reports were issued: a definitive genetic diagnosis, refer-
ring to a situation in which a pathogenic mutation was encoun-
tered in a known disease gene explaining the phenotype of the
patient (n = 13; Group 1); a possible diagnosis, referring to a
situation where a (likely) pathogenic variant was identified in a
gene not yet associated with disease (n = 16; Group 2); or no
genetic diagnosis (n = 21; Group 3). This study was approved by
themedical ethics committee of the RadboudUniversityMedical
Center under the realm of diagnostic exome sequencing.
Participants and Data Collection
To assess the value of WES test results for the daily life of
parents, we conducted in-depth, semi-structured interviews,
preferably face-to-face at parents’ homes which allowed for
observation of the family’s daily life. In some cases,
interviews were conducted by telephone. Respondents were
recruited via the pediatric neurologists (JS, MW) involved in
our translational study. Once verbal consent of parents was
obtained, the interviewer (LK) called the parents to make an
appointment for the interview.1 In total, interviews were con-
ducted with parents of 15 children: 10 couples and 6 single
parents. Six of the 15 patients received a definitive diagnosis
by WES (group 1), including Kabuki syndrome (de novomu-
tation KDM6A), MECP2 duplication syndrome (maternally
inherited X-linked duplication), 16p microdeletion syndrome
(de novo deletion), congenital Rett syndrome (de novo muta-
tion FOXG1), autosomal dominant mental retardation 5 (de
novomutation SYNGAP1), and a de novomutation in a novel
candidate gene leading to intellectual disability (PHIP). Five
of the 15 patients received the message that a lead for a pos-
sible genetic diagnosis was identified, yet needed further con-
firmation (group 2). In four patients no genetic cause was
identified (group 3). No incidental findings were reported in
the patients and interviewees (i.e., an unexpected finding un-
related to the medical condition the patient is receiving the
sequencing for but of medical importance for patient care).
The interviewees lived in the Eastern and Southern parts of
the Netherlands, and all but one were of Caucasian origin.
A semi-structured interview protocol was developed which
included twenty open questions and probes as this tactic
allowed us to gain a rich insight into parents’ experiences.
The protocol covered two main topics: 1) parents’ evaluation
of the WES-counselling procedure, including questions
concerning motivations, informed consent, and incidental
findings, and 2) parents’ evaluation of whether and how the
WES test results changed their daily life with their child. This
paper primarily addresses parents’ responses to questions
concerning how WES impacted their daily lives (2), for in-
stance: BCan you describe what it means to live with a child
with a medical condition?^ BCan you describe your day-to-
day activities?^ BDo you connect with peers (parents in sim-
ilar situations)?^ BCan you describe whether and how the
WES test results influenced your already-established relations
with peers?^ (For more information on parents’ evaluation of
the WES counselling protocol, see Krabbenborg et al. 2015.)
The aim of the interviews was to gain insight into a variety of
themes. The interviews were carried out one at a time and
when no new themes arose, and thus saturation was achieved,
we ended our data collection (Evers 2007). The interviews
lasted approximately 1–1.5 h.
For groups 1 and 3, interviews were scheduled within
2 months after receiving the results, whereas for group 2 these
took place within 2 to 6 months after receiving the diagnosis.
In addition, additional telephone interviews were conducted
after 6 months with four of six parents in group 1 to allow us to
compare longer-term experiences, specifically between
1 One interview was carried out by author SvdB
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having a conclusive diagnosis and a possible diagnosis.
Follow-up interviews with parents from group 3 were not
initiated as we anticipated not much had changed in their
situation.
Data Analysis
The interviews were recorded and transcribed verbatim. The
transcripts were uploaded in Atlas-ti 7.1. By using a content
analysis approach (Boeije 2012; Vaismoradi et al. 2013), a
coding scheme was developed that reflected central themes
articulated by parents. Researcher LK and SvdB independent-
ly coded first transcripts to inductively ascribe codes. Final
consensus on the coding scheme was reached through discus-
sion. Examples of codes are Bconfirmation of being a respon-
sible parent^ (definitive diagnosis) and Bfeelings of isolation^
(definitive and possible diagnosis).
Results
Throughout the interviews we found that all families who live
with a child with a (presumed) genetic disease engage in sim-
ilar activities as each other. These activities can be seen as the
interpretative framework that shapes parental experiences
with the child as well as their assessment of WES test results,
and can be classified into three categories:
& seeking knowledge about the child’s condition and
prognosis;
& caregiving activities and management of care; and
& finding a supportive environment.
We will describe these core activities and show how WES
results influence them. Illustrative quotes are presented in text
boxes and have been translated from Dutch.
Seeking Knowledge about the Child’s Condition
and Prognosis
Parents living with a child with a rare, presumably genetic
disease are often confronted with uncertainties because
they lack information about the condition, prognosis, ther-
apy and recurrence risk of the disease. To meet this uncer-
tainty, or as a coping mechanism, parents try to gather as
much information as possible; for example, by visiting one
medical specialist after another (cf. the Bdiagnostic
odyssey^), by searching the internet, but also by exchang-
ing information with other parents with children with sim-
ilar complaints via social media and through participating
in patient organizations. With WES, parents hoped to ob-
tain a diagnosis, which would allow them to gather more
information from all sources listed above.
When receivingWES test results, parents from all the three
groups (definite diagnosis, possible diagnosis, and no diagno-
sis) experienced relief as well as worries. Parents who re-
ceived a definitive diagnosis appreciated having a confirma-
tion of their suspicion that their child’s condition truly had a
medical cause, and was not a result of medical malpractice
during birth or parental carelessness or deficient upbringing.
Parents also valued the fact that the diagnosis provided more
insight into the inheritance and recurrence risks. On the other
hand, receiving a definitive diagnosis implied a loss of hope
for some parents. While parents participated in WES because
they wanted to know the cause of the child’s condition, our
data suggest that some parents hoped more information about
their child’s disease would lead to better treatment, and even
hoped for some miraculous recovery to happen. For some of
the parents the diagnosis was disappointing because it pointed
towards a syndrome, and they considered Ba syndrome^ as
something that cannot be cured, in contrast to Ba disease.^
Other parents receiving a definitive diagnosis were relieved
because it pointed to a better prognosis than initially thought.
Yet, they were also disappointed because their health care
providers knew little to nothing about their child’s disease.
In response to this problem, some parents took control; they
collected the information about the disease and distributed it to
other (local) health care specialists to inform them about the
child’s diagnosis and the medical condition itself.
Parents receiving a Bpossible diagnosis^ responded to it
with ambivalence: on the one hand, they continued the search
for a definitive diagnosis (hope), and on the other hand they
made efforts to come to terms with the situation (acceptance).
Additionally, in specific cases where a maternally inherited X-
linked recessive mutation was mentioned as the potential
cause of disease (requiring further familial segregation stud-
ies), the possible diagnosis generated led to new worries, un-
certainties, and insecurities.
Parents who received no diagnosis varied in their re-
sponses. Some were relieved that nothing was found in the
genes of their child, but some were also concerned because
they still longed for an explanation of their child’s symptoms.
Text box 1: Quotations illustrating thatWES test results evoke
ambivalent responses
Longing for a conclusive
diagnosis
BThe neurologist called and told us that they
did not find a diagnosis. And to be
honest, that was disappointing. I know
this may sound strange, because on the
one hand you do not want to hear that
there is something wrong with your
child, but on the other hand, she is still
diseased.^ (no diagnosis, interview 8)
BOn the one had I am glad that they did not
find something in her genes (…) but on
the other hand, we are still facing
uncertainties. What is the cause? Did
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something happen during pregnancy, or
is it something genetic? (no diagnosis,
interview 10)
BI hope that technology will improve in
such a way, that 1 day, we will receive a
definitive diagnosis. But on the other
hand, if she [the child] continues to
develop the way she does now, then I
think we do not need to know the cause
because she is doing fine right now. And
therefore, so do we. But when her
situation worsens, and that might happen
you know, then you do want to have a
diagnosis in order to prepare yourself for
what might happen.^ (possible
diagnosis, interview 19)
Loss of hope BOn the one hand you are relieved or even
happy (…) because you know the cause,
but on the other hand you become aware
of all the things that are not possible
anymore. It is like an emotional
rollercoaster (…) you realize the
situation [of the child] will not change.
With that muscle disease we thought
‘Well, let us give him some medication
and he will improve, and something like




BWhen we heard it is not mitochondrial
disease, you think ‘Yay, champagne!’
(…) but this new diagnosis is too vague
right now. Not much is known yet and
the information we did receive is very
broad and general, like ‘It might be
that…or it is possible that…’ (…) there is
no written information on this syndrome
(…) but I want to have proof. I want to
show other healthcare specialists, ‘Look
here, this is what is wrong with my child’
(…) you know, I want to move forward
and arrange the care my child needs.^
(conclusive diagnosis, interview 2)
BThere is a specialist on this disease, but he
lives in the United States. That is a pity
(…) I think scientists are not interested in
this disease because it is so rare. But I
hope that 1 day, more information will
become available.^ (conclusive
diagnosis, interview 1)
BI visited our family doctor and asked: ‘Do
you know what is wrong with our child?’
‘No’ was his answer. I did not receive
any information about the diagnosis.
And that annoys me you know,
something is found, and he knows
nothing about it.^ (conclusive diagnosis,
interview 2)
Parents dealing with new
information
BI find it hard to deal with the results. I
mean they told us that [next to mutation
in DNA of child] also something is
found, in my [the mother] X-
chromosome, but we do not know for
sure whether this mutation is the cause.
Nobody in our family has this disease
(...) so is it just accidental? We just do not
know, and that is difficult to deal with.
For now, they [the clinicians] cannot give
us any further explanation.^ (possible
diagnosis, interview 20)
BOne of the parents we met at the
conference developed a leaflet to raise
awareness about this new syndrome. I
ordered some copies and distributed that
within our local hospital and day-care.^
(conclusive diagnosis, interview 1, after
6 months)
Caring Activities; Management of Care
Parents with a diseased child are perpetually confronted with a
burden of care. Their daily care duties cover a wide range of
activities, including nursing a disabled child, obtaining the nec-
essary resources and equipment (e.g., a wheelchair), seeking spe-
cialized professional help to alleviate complaints, and adminis-
trative tasks such as keeping up to date with insurance regula-
tions. These caregiving duties are demanding, and some parents
described their engagement in them as a continuous Bbattle.^
Because of the nature of this consuming work, some parents—
mostly mothers—resigned from their jobs and others decided to
work fewer hours. In some cases, having a diseased child also led
to financial struggles as not all care-associated costs are reim-
bursed by either the healthcare system and/or government (e.g.,
adapting the house to their child’s wheelchair needs).
Parents in this study expressed hope that a diagnosis will
improve care. In a few cases, the diagnosis indeed led to im-
provements such as referral to a different health professional,
or support to arrange the necessary equipment.
One parent couple receiving a conclusive diagnosis initial-
ly felt empty-handed because of the lack of precise informa-
tion on the prognosis and daily management; however, after
6 months they indicated the diagnosis and the neurologist’s
referral to a rehabilitation physician enabled them to attune
care facilities more closely to the needs of their child.
Parents receiving no diagnosis also reported there were no
changes in the daily management of their child’s care.
In cases where a definitive diagnosis did not lead to (major)
changes or improvements in daily care, it did initiate shifts in
the parents’ consideration of themselves as Bgood, responsible
parents.^ For example, one parent couple mentioned feeling
insecure about their decisions regarding therapies for their
child, because they felt judged by members of their social
circle; to them the diagnosis was a confirmation that they were
acting responsibly. After 6 months, two parent couples who
had received conclusive diagnoses also mentioned having be-
come more accepting towards the situation as it is. In contrast,
two parent couples, respectively receiving a possible and no
diagnosis, reported having to juggle between feelings of
accepting and enjoying their child and still longing for a (con-
clusive genetic) diagnosis in the future.
1210 Krabbenborg et al.
Text box 2 Quotations that illustrate managing burden of care
Changes in daily care
management of the child
BThe diagnosis did not really change
things, but we have made an
appointment with the ophthalmologist as
the gene in which the mutation is found
is linked to eye disease.^
(Possible diagnosis, interview 18)
BBased upon the WES test results, our
rehabilitation physician initiated more
therapy and prescribed leg splints for the
night.^ (possible diagnosis, interview 17)
BOur neurologist referred us to a
rehabilitation physician. That opened
doors. We now have a wheelchair and a
special needs bike for our child.^
(conclusive diagnosis, interview 2, after
6 months)
Enhancing coping process BWe accepted the fact that not much is
known about this syndrome. It is our
task to make the best of this situation.^
(conclusive diagnosis, interview 1)
BI hope science will deliver answers, but in
the meantime, we have to enjoy our
child as much as possible.^ (possible
diagnosis, interview 19)
BYou know, a diagnosis does mean
something (...) it does not provide a
solution to our problems, our child will
not get better. But for the coping process
(...) you can come to terms with the
situation (…) you see the difference (…)
S. does actually have a [clinical]
diagnosis, and yes, the fact that she has
to use the wheelchair once in a while is
more easy to accept for us, because
indeed, long distances are too tiring for
her (…) you accept that, why? Because
it is allowed. Because S. has a [clinical]
disorder [for which the cause has not
been identified yet], and she really needs
the wheelchair. But actually, N. [an
affected sister of the diseased child who,
at the time of the interview, had neither a
clinical nor genetic diagnosisa] has the
same problems [in mother’s opinion],
but then you start thinking: ‘Why do you
[N.] want to be in a wheelchair? Is it not
just in your head?’While really, she [N.]
is so tired.^ (no diagnosis, interview 8)
Confirmation of being a
responsible parent
BAnd you feel uncomfortable… or you will
be more harsh towards your child. Not
because you want to, but to prove to
others that you are also critical, and you
know, you think about all these things.
And now, when there is a diagnosis, it
does, it gives you a feeling of BI told you
so, we were right.^ (conclusive
diagnosis, interview 6)
BThat a gene mutation is found is a
confirmation that it is not our fault. You
know, we struggled with the idea that
maybe we did not challenge him enough
when he was a baby. And moreover, he
fell off the changing unit once, and I
always wondered whether this fall had
anything to do with his disease.^
(conclusive diagnosis, interview 9)
aN., the sister of the patient included in our study has mean-
while been seen by a clinical geneticist and has been diag-
nosed with a different disorder than her sister, for which the
genetic cause has been identified
Finding a Supportive Environment
Having a diseased child also influences the social life of par-
ents. The extensive caring activities make it more difficult for
parents to join in social activities outdoors, which sometimes
leads to diminished friendships and other social contacts.
Some parents established new social contacts, for example,
through a patient organization, by meeting other parents at
specialized care facilities, or through social media. Other par-
ents, by contrast, mentioned not wanting to be part of a peer
support community because they anticipated that only sor-
rows about the diseased child would be shared, while they
wanted to highlight positive aspects.
Our interview data suggest that WES-results led to
renewed feelings of isolation for some parents receiving con-
clusive and possible diagnoses. As WES produced a Bnew
label^ for the child’s disorder, some parents no longer felt at
home in their patient organizations. Parents experienced this
as a loss as they valued the exchange with—and support
from—other parents within a patient organization.
Despite initial feelings of isolation, a conclusive diagnosis
also enabled parents to establish new relationships with peers.
After receiving the diagnosis, parents searched the internet for
more information on the diagnosis and came across blogs,
Twitter messages, and Facebook pages of other parents.
Some of the parents contacted parents on the other side of
the world via internet, whereas others reported that language
was a hurdle for sharing their experiences. Moreover, some
parents expressed not feeling an urge to establish contacts
because symptoms may differ so much, even though children
may have the same syndrome.
Text box 3: Quotations that illustrate experiences concerning
peer relations
Loss of peer support
networks
BI was really active for [patient organization].
Yeah really focused. But now this moves to
the background a bit. I think that is a pity.
With regard to our new diagnosis, not many
people have this disease. The neurologist
told me that there are only two other patients
with the same diagnosis here in the
Netherlands.^ (conclusive diagnosis,
interview 1)
I am no longer active on that forum, but I still
read the stories of other parents once in a
while. And it is still informative as we share
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the same concerns and struggles (…) but I
feel, or I doubt, whether the other parents
still want me there (…) I try not to respond
asmuch as I did before because our child has
a less severe prognosis now. And maybe the
other parents do not like that.^ (conclusive
diagnosis, interview 5)
BI could of course ask whether there are more
children within our patient organization who
have a mutation on the [name of gene], but
there is no point in doing that. I already
know that nobody knows this gene. That is
the situation we have to deal with.^ (possible
diagnosis, interview 19)
BWe do not have a name of a syndrome for
which we can fight, by raising funding for
example. Other parents do. And then, yeah,
then you have your back against the wall.^
(possible diagnosis, interview 19)
Establishing relations
with new peers
BI googled and there is indeed a forum, of
course, very very small as it concerns a new
syndrome, but I do not feel prompted to
respond or share my story. I want to
highlight the positive and the forum focuses
on the negative aspects. (conclusive
diagnosis, interview 2)
BFor this syndrome we found a forum hosted
by people from the United States. I am not
active [on the forum] as I find the English
language difficult (.) The forum is useful to
receive suggestions (...) and we see physical
similarities between our child and theirs.
Although seeing these similarities is not
exactly a nice feeling, but that’s what it is.^
(conclusive diagnosis, interview 5)
Discussion
Practice Implications
Parents’ evaluations of a genetic diagnosis, as found in this
study, can provide insight into psychosocial aspects that
should be taken into account in pre-test as well as post-test
counselling. Though our study was carried out in a pediatric
neurology setting, the findings offer some insight for other
medical specialists who deal withWES test results and genetic
counselling.
In agreement with previous research, our results show that
genetic test results are not only a biomedical description to
parents, explaining the genetic cause for malfunction or disease
(De Ligt et al. 2012; Vissers et al. 2010). Parents also use
genetic test results to deal with the social dimension of having
a diseased child. In some cases, WES results offer, for exam-
ple, a label for the condition of their child which allows parents
to explain the child’s behaviour to the outside world, organize
adequate care, and identify with a supportive group of peers
(Eisenberg 1977; Hofmann 2002;Whitemarsh et al. 2007).We
found, however, that the WES diagnosis did not always match
the identity of the patient organizations the parents had joined
in the past, and parents often no longer felt at home in their peer
support groups. Consequently some parents mourned the loss
of the support and friendships they had enjoyed there.
Parents receiving a possible diagnosis in particular, experi-
enced a loss of peers as their Bpeers^ still remain to be iden-
tified. Moreover, new uncertainties were evoked in cases
where a presumable maternally inherited X-linked recessive
mutation was identified. For those parents who received a
conclusive diagnosis, one would expect that if WES is used
as first-tier diagnostic test in routine clinical practice, it could
enable parents to find adequate peer support more quickly and
easily. Our results suggest, however, that a conclusive diagno-
sis will sometimes create difficulties. When WES identifies
the cause of a rare disease or syndrome, peer support groups
are often (still) small and international. The international as-
pect requires parents to express themselves in a foreign lan-
guage, and some parents cannot exchange their experiences
with peers or feel hesitant to do so because of the language
barrier. Other parents with more proficiency in English and
who received a conclusive diagnosis were enabled to connect
with peers world-wide and share experiences via social media
(see also Fanos 2012; Reiff et al. 2012).
Genetic counsellors should prepare parents for these diffi-
culties before the test and continue to support them after test
results have been obtained. What is important to keep in mind
is that even when WES provides a diagnosis and ends the
diagnostic odyssey, it may at the same time open up a new
Bodyssey.^ Specifically, it may engage parents who received a
conclusive diagnosis in a search for information about their
child’s (very rare) disease and the establishment of new care
arrangements, as well as a search for new peer contacts, which
may be accompanied by (temporarily) mourning the loss of
previous contacts. Furthermore, for parents who receive a
possible diagnosis, or no diagnosis at all, there are little chang-
es: they will continue to search for a diagnosis and will con-
tinue to be uncertain about the cause of their child’s disease
until a confirmed diagnosis can be provided. Parents who
receive a possible diagnosis, however, may in addition lose
peer-contacts if the received lead for a diagnosis does not
coincide with the identity of the patient organization they
joined previously.
It is important that counsellors are aware of these uncer-
tainties and losses that parents may suffer in their private lives,
even if they receive the diagnosis for which they longed.
While single gene testing also raises hopes as well as uncer-
tainties, testing with WES will increasingly confront parents
with diagnoses of very rare diseases about which little knowl-
edge may be available. For counsellors this means they will
have to inform and support parents, even though they may
themselves have little to no previous experience with a disease
(cf. Navon 2012). This may complicate the counselling pro-
cess. Our research suggests that it may be advisable to prepare
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parents in advance for this continued uncertainty after
obtaining the test results, and to provide them with follow-
up care in order to deal with the concerns and questions raised
by the results (Krabbenborg et al. 2015). Furthermore, coun-
sellors can re-contact parents and inform them when new lit-
erature about their child’s disease becomes available in order
to diminish their uncertainty (see also Reiff et al. 2012).
Counsellors can also help parents connect with new peers
around the globe. Different from targeted genetic testing,
WES has the intrinsic risk of the identification of incidental
or secondary findings. Our study has shown that the identifi-
cation of potential diagnostically relevant sequence variants in
the parents (e.g., X-linked recessive mutations in mothers)
leads to new questions and uncertainties. Yet, we have previ-
ously shown that the desire of parents to identify the cause of
their child’s disease nullifies any pre-test distress on the po-
tential risk of identifying any medically relevant genetic var-
iants in their own DNA (Krabbenborg et al. 2015). This com-
bination of factors indicates that sufficient amounts of time
should spent in pre- and post-test counselling to ensure parents
understand the potential risks of the test and how such poten-
tial risks may affect their lives.
Study Limitations
Several factors may have influenced our results. Firstly, we
recruited respondents from one (tertiary) hospital, in one
country (and thus one type of healthcare system). In addition,
the vast majority of all interviewees (95 %) were of Caucasian
origin. Therefore, our results may not be representative for
families worldwide using WES as a diagnostic test. Second,
while it is a strength of our study that we included all three
types of test results that can be obtained using WES (i.e., a
conclusive, possible, or no genetic diagnosis), enabling us to
make a comprehensive comparison of the experiences obtain-
ed in these groups, we did not initiate follow-up interviews
with parents receiving no diagnosis. This creates limita-
tions in comparing longer-term experiences. Third, the
small samples for each groups make it difficult to draw
conclusions about thematic differences due to type of result
received. Fourth, there was variability in time regarding
carrying out the interviews. This might have influenced
the results; for instance, parents from group 2 (possible
diagnosis) were interviewed 2 to 6 months after they re-
ceived the test results and thus had more time to experience
how the WES test results influenced their daily life than
parents from group 3 (no diagnosis) who were interviewed
within 1 to 2 months after they received the test results.
Finally, as some interviews were conducted by telephone,
this may have influenced the results through the absence of
non-verbal cues; additional probing questions aimed at ac-
quiring more insight, in response to certain types of non-
verbal behaviors, are not possible on the telephone.
Research Suggestions
A study with more respondents across hospitals and nations
would be worthwhile as it would allow for deeper insight
into, for instance, whether and how culture, class and dif-
ferent healthcare systems influence parents’ experience
WES test results in daily life. Secondly, longitudinal re-
search into all three types of WES test results (conclusive,
possible, no genetic diagnosis) would be useful to monitor
how parents cope with WES test results over a longer peri-
od. It may, for instance, be expected that patients receiving
a possible genetic diagnosis will in the future receive a
definitive one when additional patients are identified.
Moreover, the increased use of WES may allow for identi-
fying more children with the same rare diseases and syn-
dromes in the near future, which is likely to alter the feel-
ings of mourning and isolation that were expressed by some
parents who lost their peer group.
Conclusions
Whereas WES has rapidly founds its way into daily genetic
diagnostic care, empirical data on the experiences of patients
and/or parents on how to deal with the WES results in their
daily life are still lagging behind. Our exploratory study aimed
to provide some of this information. Our main conclusion is
that WES test results evoked ambivalent responses, irrespec-
tive of the type of test result they obtained. Specifically, a
conclusive diagnosis enabled parents to 1) become more
accepting towards the situation; 2) cope with feelings of guilt;
3) deal with the outside world; and 4) attune caregiving activ-
ities to the child’s needs. In addition, a conclusive diagnosis
confirmed for parents that they were on the right track with
regard to arranging therapies for the child. Parents receiving a
possible diagnosis also used the diagnosis to adjust caring
activities more to the needs of the child. However, a diagnosis
could also elicit new worries, such as in the case of the poten-
tial X-linked mutations which were identified in the mother.
Parents receiving no diagnosis vacillated between accepting
that they have to continue living with uncertainty and longing
for a continuation of research in order to receive a diagnosis at
a later stage. Whereas most of these experiences cohere with
previous studies in the context of rare genetic syndromes
(Bosma et al. 2015; Brooks-Howell 2006; Graungaard and
Skov 2006; Hallberg et al. 2010; Reiff et al. 2012; Skirton
2001; Webb 2005), they have not been studied in a largely
unselected patient cohort with a presumed genetic disease. For
example, the likelihood of these patients receiving a genetic
diagnosis using WES was much greater than when testing for
genetic syndromes by gene-specific Sanger sequencing tests.
In addition, the potential for WES to result in Bpossible^ di-
agnoses, where further research is needed for confirmation,
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may pose new uncertainties, and our study yielded some ini-
tial insights into how parents deal with them.
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